Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Historical Holders from Q2 2021 to Q1 2025

Symbol
DAWN on Nasdaq
CUSIP
23954D109
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
93.7M
Holdings value
$1.19B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
164
Number of buys
86
Number of sells
-72
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 12.8% $102M 12.9M FMR LLC Dec 31, 2024
RA CAPITAL MANAGEMENT, L.P. 5.7% $45.6M 5.76M RA Capital Management, L.P. Dec 31, 2024

Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 326K $2.59M +$111K $7.93 14
2024 Q4 93.7M $1.19B -$3.74M $12.67 164
2024 Q3 91.9M $1.28B +$237M $13.93 165
2024 Q2 74.6M $1.03B +$21.2M $13.78 154
2024 Q1 72.6M $1.2B -$58.7M $16.52 145
2023 Q4 76.5M $1.12B -$50.5M $14.60 135
2023 Q3 77.3M $949M -$24.3M $12.27 124
2023 Q2 78.6M $938M +$206M $11.94 133
2023 Q1 61.1M $816M -$9.34M $13.37 119
2022 Q4 59.8M $1.29B -$37.7M $21.52 102
2022 Q3 60.2M $1.21B +$22M $20.03 84
2022 Q2 59.3M $1.06B +$302M $17.90 79
2022 Q1 43.3M $430M +$13.1M $9.92 65
2021 Q4 41.5M $698M +$74.6M $16.85 56
2021 Q3 19M $450M +$33.8M $23.73 44
2021 Q2 17.7M $401M +$401M $22.77 32